Neurymenolide A, a novel mitotic spindle poison from the New Caledonian Rhodophyta Phacelocarpus neurymenioides

2019

Article référencé dans le Web of Science WOS:000460795500021

Motuhi S. E., Feizbakhsh O., Foll-Josselin B., Baratte B., Delehouze C., Cousseau A., Fant X., Bulinski J. C., Payri Claude, Ruchaud S., Mehiri M., Bach S.

Marine Drugs, 2019, 17 (2), art. 93 [18 p.] ISSN 1660-3397

The marine -pyrone macrolide neurymenolide A was previously isolated from the Fijian red macroalga, Neurymenia fraxinifolia, and characterized as an antibacterial agent against antibiotic-resistant strains that also exhibited moderate cytotoxicity in vitro against cancer cell lines. This compound was also shown to exhibit allelopathic effects on Scleractinian corals. However, to date no mechanism of action has been described in the literature. The present study showed, for the first time, the isolation of neurymenolide A from the New Caledonian Rhodophyta, Phacelocarpus neurymenioides. We confirmed the compound's moderate cytotoxicity in vitro against several human cell lines, including solid and hematological malignancies. Furthermore, we combined fluorescence microscopy and flow cytometry to demonstrate that treatment of U-2 OS osteosarcoma human cells with neurymenolide A could block cell division in prometaphase by inhibiting the correct formation of the mitotic spindle, which induced a mitotic catastrophe that led to necrosis and apoptosis. Absolute configuration of the stereogenic center C-17 of neurymenolide A was deduced by comparison of the experimental and theoretical circular dichroism spectra. Since the total synthesis of this compound has already been described, our findings open new avenues in cancer treatment for this class of marine molecules, including a new source for the natural product.

Sciences fondamentales / Techniques d'analyse et de recherche [020] ; Substances naturelles [035]

NOUVELLE CALEDONIE

Fonds IRD [F B010075313]

fdi:010075313